Due to the prolonged overall survival of CLL patients, there was insufficient observation time to evaluate the effects of smudge cell count, surface CD20, and soluble CD20 levels on prognosis and overall survival. This evidence concerns the gene MS4A1 and B-cell chronic lymphocytic leukemia.